N-linked oligosaccharides and metastatic propensity in in vivo selected mouse mammary adenocarcinoma cells

Clinical and Experimental Metastasis

Volumn 17, Issue 5, 1999, Pages 437-444

  James Seberger, P ^a   Scholar, Eric M ^b   Kelsey, Linda ^b   Chaney, William G ^a   Talmadge, James E ^b  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Breast cancer; Carbohydrate; Glycosylation; Invasion; Metastasis

Indexed keywords

ASPARAGINE LINKED OLIGOSACCHARIDE;

ANIMAL CELL; ARTICLE; BASEMENT MEMBRANE; BREAST ADENOCARCINOMA; CANCER INVASION; CARCINOMA CELL; CELL TRANSFORMATION; DENSITOMETRY; GLYCOSYLATION; IN VIVO STUDY; METASTASIS POTENTIAL; MOLECULAR CLONING; MOUSE; NONHUMAN; TUMOR GROWTH; TUMOR VOLUME;

ADENOCARCINOMA; ANIMALS; FEMALE; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; N-ACETYLNEURAMINIC ACID; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; OLIGOSACCHARIDES; TUMOR MARKERS, BIOLOGICAL;

EID: 0011397856     PISSN: 02620898     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006629119030     Document Type: Article

References (50)

1. 1. Nowell PC. The clonal evolution of tumor cell populations. Science 1976; 194(4260): 23-8.
2. 2. Talmadge JE, Fidler IJ. Phenotypic heterogeneity and metastasis. In Sirica AE (ed): The Pathobiology of Neoplasia. Plenum Publ. Corp 1998; 547-72.
3. 3. Dennis JW, Laferte S, Waghorne C et al. Beta 1-6 branching of Asnlinked oligosaccharides is directly associated with metastasis. Science 1987; 236(4801): 582-5.
4. 4. Yogeeswaran G, Salk PL. Metastatic potential is positively correlated with cell surface sialylation of cultured murine tumor cell lines. Science 1981; 212(4502): 1514-6.
5. 5. Cummings RD, Trowbridge IS, Kornfeld S. A mouse lymphoma cell line resistant to the leukoagglutinating lectin from Phaseolus vulgaris is deficient in UDP-GlcNAc: Alpha-D-mannoside beta 1,6 N-acetylglucosaminyltransferase. J Biol Chem 1982; 257(22): 13421-7.
6. 6. Fernandes B, Sagman U, Auger M et al. 1-6 branched oligosaccharides as a marker of tumor progression in human breast and colon neoplasia [see comments]. Cancer Res 1991; 51(2): 718-23.
7. 7. Takano R, Nose M, Nishihira T, Kyogoku M. Increase of beta 1-6-branched oligosaccharides in human esophageal carcinomas invasive against surrounding tissue in vivo and in vitro. Am J Pathol 1990; 137(5): 1007-11.
8. 8. Dennis JW, Laferte S. Oncodevelopmental expression of-GlcNAc 1-6Man α 1-6Man β1 - branched asparagine-linked oligosaccharides in murine tissues and human breast carcinomas. Cancer Res 1989; 49(4): 945-50.
9. 9. Rye PD, Fodstad O, Emilsen E, Bryne M. Invasion potential and N-acetylgalactosamine expression in a human melanoma model. Int J Cancer 1998; 75(4): 609-14.
10. 10. Pierce M, Arango J. Rous sarcoma virus-transformed baby hamster kidney cells express higher levels of asparagine-linked tri-and tetraantennary glycopeptides containing [GlcNAc-beta (1,6)Man-alpha (1,6)Man] and poly-N-acetyllactosamine sequences than baby hamster kidney cells. J Biol Chem 1986; 261(23): 10772-7.
11. 11. Takasaki S, Ikehira H, Kobata A. Increase of asparagine-linked oligosaccharides with branched outer chains caused by cell transformation. Biochem Biophys Res Commun 1980; 92(3): 735-42.
12. 12. Lu Y, Chaney W. Induction of N-acetylglucosaminyltransferase V by elevated expression of activated or proto-Ha-ras oncogenes. Mol Cell Biochem 1993; 122(1): 85-92.
13. 13. Hebert E, Monsigny M. Oncogenes and expression of endogenous lectins and glycoconjugates. Biol Cell 1993; 79(2): 97-109.
14. 14. Dennis JW. Effects of swainsonine and polyinosinic:polycytidylic acid on murine tumor cell growth and metastasis. Cancer Res 1986; 46(10): 5131-6.
15. 15. Goss PE, Reid CL, Bailey D, Dennis JW. Phase IB clinical trial of the oligosaccharide processing inhibitor swainsonine in patients with advanced malignancies. Clin Cancer Res 1997; 3(7): 1077-86.
16. 16. Yagel S, Kerbel R, Lala P et al. Basement membrane invasion by first trimester human trophoblast: Requirement for branched complex-type Asn-linked oligosaccharides. Clin Exp Metastasis 1990; 8(4): 305-17.
17. 17. Seftor RE, Seftor EA, Grimes WJ et al. Human melanoma cell invasion is inhibited in vitro by swainsonine and deoxymannojirimycin with a concomitant decrease in collagenase IV expression. Melanoma Res 1991; 1(1): 43-54.
18. 18. Demetriou M, Nabi IR, Coppolino M et al. Reduced contact-inhibition and substratum adhesion in epithelial cells expressing GlcNAc-transferase V. J Cell Biol 1995; 130(2): 383-92.
19. 19. Dexter DL, Kowalski HM, Blazar BA et al. Heterogeneity of tumor cells from a single mouse mammary tumor. Cancer Res 1978; 38(10): 3174-81.
20. 20. Miller FR, Miller BE, Heppner GH. Characterization of metastatic heterogeneity among subpopulations of a single mouse mammary tumor: heterogeneity in phenotypic stability. Invasion Metastasis 1983; 3(1): 22-31.
21. 21. Brasaemle DL, Attie AD. Microelisa reader quantitation of fixed, stained, solubilized cells in microtitre dishes. Biotechniques 1988; 6(5): 418-9.
22. 22. Lin TH, Rosales C, Mondal K et al. Integrin-mediated tyrosine phosphorylation and cytokine message induction in monocytic cells. A possible signaling role for the Syk tyrosine kinase. J Biol Chem 1995; 270(27): 16189-97.
23. 23. Massague J, Czech MP. The subunit structures of two distinct receptors for insulin-like growth factors I and II and their relationship to the insulin receptor. J Biol Chem 1982; 257(9): 5038-45.
24. 24. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227(259): 680-5.
25. 25. Nicolson GL. Tumor cell instability, diversification, and progression to the metastatic phenotype: From oncogene to oncofetal expression. Cancer Res 1987; 47(6): 1473-87.
26. 26. Fidler IJ, Hart IR. Biological diversity in metastatic neoplasms: origins and implications. Science 1982; 217(4564): 998-1003.
27. 27. Fidler IJ. Selection of successive tumour lines for metastasis. Nat New Biol 1973; 242(118): 148-9.
28. 28. Price JE, Aukerman SL, Fidler IJ. Evidence that the process of murine melanoma metastasis is sequential and selective and contains stochastic elements. Cancer Res 1986; 46(10): 5172-8.
29. 29. Talmadge JE, Fidler IJ. Enhanced metastatic potential of tumor cells harvested from spontaneous metastases of heterogeneous murine tumors. J Natl Cancer Inst 1982; 69(4): 975-80.
30. 30. Talmadge JE, Fidler IJ. Cancer metastasis is selective or random depending on the parent tumour population. Nature 1982; 297(5867): 593-4.
31. 31. Talmadge JE. The selective nature of metastasis. Cancer Metastasis Rev 1983; 2(1): 25-40.
32. 32. Talmadge JE, Benedict K, Madsen J, Fidler IJ. Development of biological diversity and susceptibility to chemotherapy in murine cancer metastases. Cancer Res 1984; 44(9): 3801-5.
33. 33. Milas L, Peters LJ, Ito H. Spontaneous metastasis: Random or selective? Clin Exp Metastasis 1983; 1(4): 309-15.
34. 34. Vaage J. Metastasizing potentials of mouse mammary tumors and their metastases. Int J Cancer 1988; 41(6): 855-8.
35. 35. Nanni P, De Giovanni C, Lollini PL et al. Clones with different metastatic capacity and variant selection during metastasis: A problematic relationship. J Natl Cancer Inst 1986; 76(1): 87-93.
36. 36. Hill RP, Chambers AF, Ling V, Harris JF. Dynamic heterogeneity: Rapid generation of metastatic variants in mouse B16 melanoma cells. Science 1984; 224(4652): 998-1001.
37. 37. Harris JF, Chambers AF, Ling V, Hill RP. Dynamic heterogeneity: Characterization of two cell lines derived from experimental lung metastases of mouse KHT fibrosarcoma. Invasion Metastasis 1987; 7(4): 217-29.
38. 38. Heimann R, Hellman S. Aging, progression, and phenotype in breast cancer. J Clin Oncol 1998; 16(8): 2686-92.
39. 39. Greller LD, Tobin FL, Poste G. Tumor heterogeneity and progression: conceptual foundations for modeling. Invasion Metastasis 1996; 16(4-5): 177-208.
40. 40. Iida J, Meijne AM, Knutson JR et al. Cell surface chondroitin sulfate proteoglycans in tumor cell adhesion, motility and invasion. Semin Cancer Biol 1996; 7(3): 155-162.
41. 41. Ling V, Chambers AF, Harris JF, Hill RP. Quantitative genetic analysis of tumor progression. Cancer Metastasis Rev 1985; 4(2): 173-92.
42. 42. Luria SDM. Mutations of bacteria from virus sensitivity to virus resistance. Genetics 1943; 28: 491-511.
43. 43. Lagarde AE. A fluctuation analysis of the rate of reexpression of the metastatic potential in a nonmetastatic mutant of the MDAY-D2 murine tumor. Invasion Metastasis 1983; 3(1): 52-64.
44. 44. Ramshaw IA, Badenoch Jones P. Studies on rat mammary adenocarcinomas: A model for metastasis. Cancer Metastasis Rev 1985; 4(3): 195-208.
45. 45. Young SD, Hill RP. Dynamic heterogeneity: Isolation of murine tumor cell populations enriched for metastatic variants and quantification of the unstable expression of the phenotype. Clin Exp Metastasis 1986; 4(3): 153-76.
46. 46. Cifone MA, Fidler IJ. Increasing metastatic potential is associated with increasing genetic instability of clones isolated from murine neoplasms. Proc Natl Acad Sci USA 1981; 78(11): 6949-52.
47. 47. Maslow DE. Tabulation of results on the heterogeneity of cellular characteristics among cells from B16 mouse melanoma cell lines with different colonization potentials. A summary of sixty reports. Invasion Metastasis 1989; 9(3): 182-91.
48. 48. Fidler IJ, Kripke ML. Metastasis results from preexisting variant cells within a malignant tumor. Science 1977; 197(4306): 893-5.
49. 49. Bolscher JG, Schallier DC, Smets LA et al. Effect of cancer-related and drug-induced alterations in surface carbohydrates on the invasive capacity of mouse and rat cells. Cancer Res 1986; 46(8): 4080-6.
50. 50. Korczak B, Dennis JW. Inhibition of N-linked oligosaccharide processing in tumor cells is associated with enhanced tissue inhibitor of metalloproteinases (TIMP) gene expression. Int J Cancer 1993; 53(4): 634-9.